Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: Uncategorized

Subscribe to Uncategorized RSS Feed

Postponement of Daubert Hearing in Zoloft Birth Defects Case

Posted in Uncategorized

U.S. District Judge Cynthia Rufe or the Eastern District of Pennsylvania made the only call she could on Tuesday: the postponement of Daubert hearing in Zoloft birth defects case until September. The multidistrict litigation (MDL) against Pfizer, claiming its popular antidepressant, Zoloft causes birth defects, came to a halt as the plaintiffs’ expert was disqualified… Continue Reading

FDA Cites Three Cases of Diabetes Associated with Abilify

Posted in Uncategorized

Between 2008 and 2009, a number of adverse events were reported to the FDA regarding second-generation (atypical) antipsychotic drugs Seroquel (quetiapine fumarate), Risperdal (risperidone), Zyprexa (olanzapine), Geodon (ziprasidone), and Abilify (aripiprazole) among children aged 6-17. Click here to read the full FDA Adverse Event Report on Atypical Antipsychotics among children (2008-2009). The report states that… Continue Reading

WARNING: Rise in Deaths Linked to Coronary Stents

Posted in Coronary Stents, Uncategorized

Recently, there has been a dramatic increase in deaths associated with coronary stents.  These tiny metal-mesh tubes, “stents,” are placed inside arteries to keep them open, ensuring adequate blood flow. According to MedlinePlus, an online medical encyclopedia curated by the US National Library of Medicine and the National Institutes of Health, “Most of the time,… Continue Reading

Former FDA Chief Wants To Gut Clinical Trials

Posted in Uncategorized

What is the “revolving door” I’m always talking about?  It’s this.  The former head of the FDA now is in private industry and he’s proposing drastic cuts to the clinical trial process.  Yet no one complains. The council’s report establishes an ambitious, yet reachable, national goal: doubling the current annual output of new medicines for… Continue Reading

More on the Alabama generics ruling

Posted in Uncategorized

Behind a paywall, but still relevant: Business groups are urging Alabama’s highest court to reconsider its recent ruling that name-brand drug makers can be held liable for injuries caused by the generic versions of their products.   Source: Generic-Drugs Court Decision Irks Businesses – WSJ.com

What Does Dr. Carl Elliott Think About Trial Lawyers? You Might Be Surprised…

Posted in Uncategorized

Noted medical doctor and ethicist Carl Elliott is the author of White Coat, Black Hat, a book about the “dark side of medicine.”  The New York Times reviewed the book and highly recommended the entertaining and extremely readable essays regarding the way our for-profit health-care system really works. He was interviewed at Pharmalot  regarding the… Continue Reading

About Dangerous Drugs

Posted in Uncategorized

My name is Justinian Lane, and I’ve been writing about dangerous and defective drugs since 2003.  In fact, one of the reasons I went to law school is because two of my family members both needed liver transplants after receiving a contaminated batch of prescription drugs.  I graduated from Michigan State University College of Law… Continue Reading

FDA Approves New Gadolinium Dye

Posted in Uncategorized

The FDA recently approved the Gadolinium dye EOVIST to be used to help detect liver problems.  This makes EOVIST somewhat unique because it’s approved to target problems with specific organs.  Like all Gadolinium dyes, this one also carries an FDA black box warning: “Gadolinium-based contrast agents increase the risk of Nephrogenic Systemic Fibrosis in patients… Continue Reading